Risk Factors for Early Cytomegalovirus Reactivation and Impact of Early Cytomegalovirus Reactivation on Clinical Outcomes after T Cell-Replete Haploidentical Transplantation with Post-Transplantation Cyclophosphamide.
Mariotti J, Legrand F, Furst S, Giordano L, Magri F, Richiardi L, Granata A, De Philippis C, Maisano V, Faraci D, Sarina B, Giaccone L, Harbi S, Mannina D, Valli V, Tordato F, Mineri R, Bramanti S, Santoro A, Bruno B, Devillier R, Blaise D, Castagna L.
Mariotti J, et al. Among authors: tordato f.
Transplant Cell Ther. 2022 Mar;28(3):169.e1-169.e9. doi: 10.1016/j.jtct.2021.12.014. Epub 2021 Dec 23.
Transplant Cell Ther. 2022.
PMID: 34954296
Free article.